• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags Beyfortus

Beyfortus News

Business

Dr Reddy's and Sanofi Collaborate to Launch Revolutionary RSV Drug Beyfortus in India

Ryan Peterson 29 Apr, 2025

Dr Reddy’s Laboratories partners with Sanofi to introduce Beyfortus, a groundbreaking RSV drug, in India. Approved globally and now in India, it aims to protect infants from severe...

Popular News

  • Business

    India's Defence Exports Skyrocket to a Record Rs 23,622 Crore in FY25, Marking a 34-Fold Increase Since 2013-14

    14 May, 2025
  • Economy

    November Sees a Slight Uptick in US Business Inventories to $2.59 Trillion

    17 Jan, 2025
  • Business

    Airtel and Tata Group End Merger Talks for DTH Business: A Strategic Shift in India's Telecom Landscape

    04 May, 2025
  • Business

    Leadership Shakeup at Hero MotoCorp: A Closer Look at the Resignations Shaking India's Top Two-Wheeler Maker

    19 Mar, 2025
  • Business

    Government Launches New Forum to Harmonize Pension Regulations Across Agencies

    01 Feb, 2025
  • Economy

    Singapore Households See Income Surge Outpacing Expenses: A Detailed Look

    09 Dec, 2024
  • Business

    Indian Stock Market Soars: BSE Sensex and Nifty50 Hit New Highs Amid FII Inflows

    26 Mar, 2025
  • Business

    Breaking the Glass Ceiling: The Persistent Gender Gap in India's Venture Capital Industry

    10 Mar, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.